{"disease":{"id":"edematous-fibrosclerotic-panniculopathy","name":"edematous fibrosclerotic panniculopathy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03526549","title":"Long-Term Study of EN3835 (CCH-aaes) in Edematous Fibrosclerotic Panniculopathy (Cellulite)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":483,"lead_sponsor_name":"Endo Pharmaceuticals","has_results":true},{"nct_id":"NCT03428750","title":"Effectiveness and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":423,"lead_sponsor_name":"Endo Pharmaceuticals","has_results":true},{"nct_id":"NCT03446781","title":"Effectiveness and Safety of EN3835 in the Treatment of Cellulite in Women","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":422,"lead_sponsor_name":"Endo Pharmaceuticals","has_results":true},{"nct_id":"NCT02942160","title":"EN3835 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":259,"lead_sponsor_name":"Endo Pharmaceuticals","has_results":true},{"nct_id":"NCT03329989","title":"Safety and Effectiveness of EN3835 in the Treatment of EFP in Women","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":158,"lead_sponsor_name":"Endo Pharmaceuticals","has_results":true},{"nct_id":"NCT04170296","title":"Real World CCH Study in Adult Females With Cellulite","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":153,"lead_sponsor_name":"Endo Pharmaceuticals","has_results":true},{"nct_id":"NCT05419505","title":"Study of Different Interventions to Reduce Bruising Following CCH-Aaes Treatment for Cellulite of the Buttocks","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":91,"lead_sponsor_name":"Endo Pharmaceuticals","has_results":true},{"nct_id":"NCT04677712","title":"Effects of Mitigation Treatments on Bruising of CCH-aaes Treatment of Buttock Cellulite","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Endo Pharmaceuticals","has_results":true},{"nct_id":"NCT04580303","title":"CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection Techniques","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Endo Pharmaceuticals","has_results":true},{"nct_id":"NCT05249257","title":"Durability and Safety of CCH With Two Different Injection Techniques in Cellulite With Laxity","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Endo Pharmaceuticals","has_results":false},{"nct_id":"NCT03675685","title":"Safety and Pharmacokinetics of a Single Dose of CCH (3.36 mg) in Subjects With EFP","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"Endo Pharmaceuticals","has_results":true},{"nct_id":"NCT03893890","title":"Durability and Safety of EN3835 in the Treatment of EFP (Cellulite) in Women","phase":"","overall_status":"COMPLETED","enrollment_count":8,"lead_sponsor_name":"Endo Pharmaceuticals","has_results":false},{"nct_id":"NCT04209530","title":"Impact of CCH Treatment of Buttock and Thigh Cellulite in Adult Women","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":7,"lead_sponsor_name":"Endo Pharmaceuticals","has_results":true},{"nct_id":"NCT04381117","title":"Long-term Durability Study of Collagenase Clostridium Histolyticum (CCH)","phase":"","overall_status":"COMPLETED","enrollment_count":7,"lead_sponsor_name":"Endo Pharmaceuticals","has_results":false}],"total":14},"guidelines":[],"source":"Drug Landscape verified database"}